These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23640498)

  • 1. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
    Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
    Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
    J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
    Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.
    Sugimoto M; Wakabayashi M; Shimizu Y; Yoshioka T; Higashino K; Numata Y; Okuda T; Zhao S; Sakai S; Igarashi Y; Kuge Y
    PLoS One; 2016; 11(3):e0152191. PubMed ID: 27010944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
    Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
    J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.
    Li Z; Fan Y; Liu J; Li Y; Huan C; Bui HH; Kuo MS; Park TS; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1577-84. PubMed ID: 22580896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.
    Li Z; Chiang YP; He M; Zhang K; Zheng J; Wu W; Cai J; Chen Y; Chen G; Chen Y; Dong J; Worgall TS; Jiang XC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158898. PubMed ID: 33545384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression.
    Mwangi SM; Peng S; Nezami BG; Thorn N; Farris AB; Jain S; Laroui H; Merlin D; Anania F; Srinivasan S
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G103-16. PubMed ID: 26564715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice.
    Dong J; Liu J; Lou B; Li Z; Ye X; Wu M; Jiang XC
    J Lipid Res; 2006 Jun; 47(6):1307-14. PubMed ID: 16508036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Total SMS Activity on LDL Catabolism in Mice.
    Li Z; He M; Chen G; Souaiaia T; Worgall TS; Jiang XC
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1251-1261. PubMed ID: 37128925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity.
    Chiang YP; Li Z; Chen Y; Cao Y; Jiang XC
    J Biol Chem; 2021 Dec; 297(6):101398. PubMed ID: 34774525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane.
    Deevska G; Dotson PP; Mitov M; Butterfield DA; Nikolova-Karakashian M
    Cells; 2021 May; 10(6):. PubMed ID: 34064003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase.
    Ternes P; Brouwers JF; van den Dikkenberg J; Holthuis JC
    J Lipid Res; 2009 Nov; 50(11):2270-7. PubMed ID: 19454763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
    Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
    Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
    Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC
    Circ Res; 2009 Jul; 105(3):295-303. PubMed ID: 19590047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.
    Sugimoto M; Shimizu Y; Zhao S; Ukon N; Nishijima K; Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Okuda T; Tamaki N; Hanamatsu H; Igarashi Y; Kuge Y
    Biochim Biophys Acta; 2016 Aug; 1861(8 Pt A):688-702. PubMed ID: 27151272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing plasma membrane sphingomyelin increases insulin sensitivity.
    Li Z; Zhang H; Liu J; Liang CP; Li Y; Li Y; Teitelman G; Beyer T; Bui HH; Peake DA; Zhang Y; Sanders PE; Kuo MS; Park TS; Cao G; Jiang XC
    Mol Cell Biol; 2011 Oct; 31(20):4205-18. PubMed ID: 21844222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.
    Ohnishi T; Hashizume C; Taniguchi M; Furumoto H; Han J; Gao R; Kinami S; Kosaka T; Okazaki T
    FASEB J; 2017 Sep; 31(9):3816-3830. PubMed ID: 28522594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia trachomatis-infected human cells convert ceramide to sphingomyelin without sphingomyelin synthases 1 and 2.
    Tachida Y; Kumagai K; Sakai S; Ando S; Yamaji T; Hanada K
    FEBS Lett; 2020 Feb; 594(3):519-529. PubMed ID: 31596951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.